14 |
DES Thrombosis How Long Patients Will Be on Dual Antiplatelet Therapy? |
Ron Waksman |
Jul. 18. 08 |
13 |
When and How do I Use DES? Practical Clinical Considerations? Case Selection, Implantation Technique, and Anti-Platelet Therapy |
Antonio Colombo |
May. 30. 08 |
12 |
ISAR-CHOICE-2: Randomized Trial of 75 mg vs 150 mg of Daily Clopidogrel in Patients Undergoing PCI |
Adnan Kastrati |
Nov. 02. 07 |
11 |
Dual Antiplatelet Therapy: How Long Should It Be Continued after DES Implantation? |
Cheol Whan Lee |
Nov. 02. 07 |
10 |
Triple Antiplatelet Therapy After Drug-Eluting Stenting in Patients with High Risk of Restenosis |
Seong-Wook Park |
Sep. 14. 07 |
9 |
Predictors of Late DES Thrombosis and Reflections on Dual Antiplatelet Therapy |
Alexandre Abizaid |
May. 11. 07 |
8 |
Optimising Antiplatelet Therapy in Patients with STEMI: Main Findings of CLARITY and COMMIT |
Zhengming Chen |
Nov. 10. 06 |
7 |
Primary PCI in Acute MI - Part II: Role of GPIIb/IIIa Inhibitors Prior to PCI |
Dariusz Dudek |
Oct. 27. 06 |
6 |
Adjunctive Platelet Glycoprotein IIb/IIIa Receptor Inhibition with Tirofiban before Primary Angioplasty Improves Angiographic Outcomes: Results of the TIrofiban Given in the Emergency Room before Primary Angioplasty(TIGER-PA) Pilot Trial |
Alan C. Yeung |
Mar. 11. 05 |
5 |
ON-TIME: A Prospective, Randomized, Multicenter Trial of Early Initiation of Glycoprotein IIb/IIIa Inhibitors Prior to Patient Transport to Facilitate Primary PCI in Acute Myocardial Infarction |
Harry Suryapranata |
Feb. 11. 05 |